down arrow

Sinopharm Group Co., Ltd.

  • Market Cap: N/A
  • Industry: Retailing
  • ISIN: CNE100000FN7
HKD
20.92
0.42 (2.05%)

Apr 02

HKG

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Sino Biopharmaceutical Ltd.
WuXi AppTec Co., Ltd.
China Medical System Holdings Ltd.
Sinopharm Group Co., Ltd.
China Resources Pharmaceutical Group Ltd.
Hygeia Healthcare Holdings Co., Ltd.
Hansoh Pharmaceutical Group Co., Ltd.
Innovent Biologics, Inc.
Akeso, Inc.
HUTCHMED (China) Ltd.
BeiGene Ltd.

Why is Sinopharm Group Co., Ltd. ?

1
High Debt Company with a Debt to Equity ratio (avg) at times
  • High Debt Company with a Debt to Equity ratio (avg) at times
2
High Debt company with Weak Long Term Fundamental Strength
3
Negative results in Jun 25
  • ROCE(HY) Lowest at 8.7%
  • RAW MATERIAL COST(Y) Grown by 9.17% (YoY)
  • INVENTORY TURNOVER RATIO(HY) Lowest at 7.85 times
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Retailing)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Sinopharm Group Co., Ltd. for you?

Low Risk, High Return

Absolute
Risk Adjusted
Volatility
Sinopharm Group Co., Ltd.
13.7%
23.05
21.59%
Hang Seng Hong Kong
8.25%
0.41
19.93%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
5.58%
EBIT Growth (5y)
-0.84%
EBIT to Interest (avg)
5.74
Debt to EBITDA (avg)
1.71
Net Debt to Equity (avg)
0.57
Sales to Capital Employed (avg)
3.03
Tax Ratio
27.95%
Dividend Payout Ratio
30.17%
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
18.45%
ROE (avg)
19.69%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
2
Industry P/E
Price to Book Value
0.30
EV to EBIT
3.87
EV to EBITDA
3.04
EV to Capital Employed
0.55
EV to Sales
0.11
PEG Ratio
NA
Dividend Yield
8.68%
ROCE (Latest)
14.25%
ROE (Latest)
14.39%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company
OPERATING CASH FLOW(Y)

Highest at HKD 23,129.25 MM

-10What is not working for the Company
ROCE(HY)

Lowest at 8.7%

RAW MATERIAL COST(Y)

Grown by 9.17% (YoY

INVENTORY TURNOVER RATIO(HY)

Lowest at 7.85 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.35 times

NET SALES(Q)

Lowest at HKD 307,253.36 MM

OPERATING PROFIT(Q)

Lowest at HKD 10,402.48 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 3.39 %

PRE-TAX PROFIT(Q)

Lowest at HKD 6,953.65 MM

NET PROFIT(Q)

Lowest at HKD 3,685.6 MM

Here's what is working for Sinopharm Group Co., Ltd.

Operating Cash Flow
Highest at HKD 23,129.25 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (HKD MM)

Here's what is not working for Sinopharm Group Co., Ltd.

Net Sales
Lowest at HKD 307,253.36 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (HKD MM)

Operating Profit
Lowest at HKD 10,402.48 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (HKD MM)

Operating Profit Margin
Lowest at 3.39 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit
Lowest at HKD 6,953.65 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (HKD MM)

Net Profit
Lowest at HKD 3,685.6 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (HKD MM)

Inventory Turnover Ratio
Lowest at 7.85 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio
Lowest at 2.35 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost
Grown by 9.17% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Download on App Store
Get it on Google Play
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."